Cargando…

Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX)

BACKGROUND. Little information is available about survival outcomes of patients with HER2-positive early breast cancer treated with adjuvant capecitabine-containing chemotherapy with or without trastuzumab. PATIENTS AND METHODS. One thousand and five hundred patients with early breast cancer were en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joensuu, Heikki, Kellokumpu-Lehtinen, Pirkko-Liisa, Huovinen, Riikka, Jukkola-Vuorinen, Arja, Tanner, Minna, Kokko, Riitta, Ahlgren, Johan, Auvinen, Päivi, Saarni, Outi, Helle, Leena, Villman, Kenneth, Nyandoto, Paul, Nilsson, Greger, Leinonen, Mika, Kataja, Vesa, Bono, Petri, Lindman, Henrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Informa Healthcare 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894716/ https://www.ncbi.nlm.nih.gov/pubmed/23957715 http://dx.doi.org/10.3109/0284186X.2013.820840

Ejemplares similares

Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial
por: Joensuu, Heikki, et al.
Publicado: (2022)

Somatic Mutation Profiling and Associations With Prognosis and Trastuzumab Benefit in Early Breast Cancer
por: Loi, Sherene, et al.
Publicado: (2013)

A graphical LASSO analysis of global quality of life, sub scales of the EORTC QLQ-C30 instrument and depression in early breast cancer
por: Poikonen-Saksela, Paula, et al.
Publicado: (2022)

High baseline Tie1 level predicts poor survival in metastatic breast cancer
por: Tiainen, Leena, et al.
Publicado: (2019)

The past and present of prostate cancer and its treatment and diagnostics: A historical review
por: Lehtonen, Miikka, et al.
Publicado: (2023)

Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy
por: Skyttä, Tanja, et al.
Publicado: (2015)

High-level cytoplasmic claudin 3 expression is an independent predictor of poor survival in triple-negative breast cancer
por: Jääskeläinen, Anniina, et al.
Publicado: (2018)

Long-term health-related quality of life of breast cancer survivors remains impaired compared to the age-matched general population especially in young women. Results from the prospective controlled BREX exercise study
por: Roine, Eija, et al.
Publicado: (2021)

ERBB4 Promoter Polymorphism Is Associated with Poor Distant Disease-Free Survival in High-Risk Early Breast Cancer
por: Kurppa, Kari J., et al.
Publicado: (2014)

3-Year Follow-Up of Radiation-Associated Changes in Diastolic Function by Speckle Tracking Echocardiography
por: Tuohinen, Suvi Sirkku, et al.
Publicado: (2021)

Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial
por: Joensuu, H., et al.
Publicado: (2010)

Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer
por: Batista, N, et al.
Publicado: (2004)

Undergraduate curriculum in palliative medicine at Tampere University increases students’ knowledge
por: Lehto, Juho T., et al.
Publicado: (2017)

Both comorbidity and worse performance status are associated with poorer overall survival after external beam radiotherapy for prostate cancer
por: Lehtonen, Miikka, et al.
Publicado: (2020)

Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2011)

Recurrent CYP2C19 deletion allele is associated with triple-negative breast cancer
por: Tervasmäki, Anna, et al.
Publicado: (2014)

Decreases in TGF-β1 and PDGF levels are associated with echocardiographic changes during adjuvant radiotherapy for breast cancer
por: Aula, Hanna, et al.
Publicado: (2018)

Transforming growth factor beta 1 levels predict echocardiographic changes at three years after adjuvant radiotherapy for breast cancer
por: Aula, Hanna, et al.
Publicado: (2019)

ST2 levels increased and were associated with changes in left ventricular systolic function during a three-year follow-up after adjuvant radiotherapy for breast cancer
por: Aula, Hanna, et al.
Publicado: (2019)

Radiotherapy-induced diffuse myocardial fibrosis in early-stage breast cancer patients – multimodality imaging study with six-year follow-up
por: Moisander, Mikko, et al.
Publicado: (2023)

Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry
por: Wirtz, Ralph M., et al.
Publicado: (2016)

Transcripts of the Prostate Cancer-Associated Gene ANO7 Are Retained in the Nuclei of Prostatic Epithelial Cells
por: Metsälä, Olli, et al.
Publicado: (2023)

Local and systemic oxidant/antioxidant status before and during lung cancer radiotherapy
por: Crohns, Marika, et al.
Publicado: (2009)

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population
por: Hallamies, Sanna, et al.
Publicado: (2017)

Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer
por: Lehtomäki, Kaisa, et al.
Publicado: (2023)

The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer
por: Peurala, Emmi, et al.
Publicado: (2013)

Treatment accuracy without rotational setup corrections in intracranial SRT
por: Boman, Eeva, et al.
Publicado: (2016)

Does special education in palliative medicine make a difference in end-of-life decision-making?
por: Piili, Reetta P., et al.
Publicado: (2018)

Changes in attitudes towards hastened death among Finnish physicians over the past sixteen years
por: Piili, Reetta P., et al.
Publicado: (2018)

Dynamic Contrast-Enhanced Imaging as a Prognostic Tool in Early Diagnosis of Prostate Cancer: Correlation with PSA and Clinical Stage
por: Wu, Xingchen, et al.
Publicado: (2018)

Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma
por: Terävä, Joonas, et al.
Publicado: (2019)

Early quality-of-life and psychological predictors of disease-free time and survival in localized prostate cancer
por: Lehto, Ulla-Sisko, et al.
Publicado: (2018)

Physicians’ decreased tendency to choose palliative care for patients with advanced dementia between 1999 and 2015
por: Haapasalmi, Saila, et al.
Publicado: (2021)

Incidence of subsequent primary cancers and radiation-induced subsequent primary cancers after low dose-rate brachytherapy monotherapy for prostate cancer in long-term follow-up
por: Vuolukka, Kristiina, et al.
Publicado: (2020)

Human breast cancer cells educate macrophages toward the M2 activation status
por: Sousa, Sofia, et al.
Publicado: (2015)

Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer
por: Lehtomäki, Kaisa, et al.
Publicado: (2021)

Rare Copy Number Variants Observed in Hereditary Breast Cancer Cases Disrupt Genes in Estrogen Signaling and TP53 Tumor Suppression Network
por: Pylkäs, Katri, et al.
Publicado: (2012)

Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer
por: VÄISÄNEN, MARJA-RIITTA, et al.
Publicado: (2013)

Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo
por: Sandholm, Jouko, et al.
Publicado: (2016)

The courses of maternal and paternal depressive and anxiety symptoms during the prenatal period in the FinnBrain Birth Cohort study
por: Korja, Riikka, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kfq833s5jmpvceel7ni6lhl6k7